Energy networks have recently submitted their final business plans to Ofgem in advance of the forthcoming RIIO price controls for transmission and gas distribution. Oxera prepared updated estimates of the cost of equity to inform the companies’ business plans. The report reflects new evidence from capital markets since the Oxera report from Q1 2018, as
Imagine a world where you could have remote access to a healthcare specialist who could assess, diagnose and potentially treat you at home; or a school lesson where you’re virtually ‘transported’ to the surface of the moon to learn about the solar system; or a meeting with colleagues who are in different parts of the
Oxera is advising National Grid Electricity System Operator (ESO) on the calibration of financial price control parameters in line with the risks faced by the company in the RIIO-2 period. Ofgem is currently establishing a new regulatory regime for National Grid ESO following the legal separation of the company from the electricity transmission business of
Very high capacity broadband networks are crucial for enabling interconnection between areas, industries and people. They facilitate interaction, collaboration, trade and the social and economic benefits that come with them. In today’s connected world, having up-to-date and future-proof digital and telecommunications infrastructure is a key strategic priority for the UK government. The Broadband Stakeholder Group (BSG)
Ofwat’s draft determinations for the non-fast-tracked companies, published a week ago, cover a wide range of issues (across several documents). Now that the dust is settling, it’s time to take stock. What are the key messages on efficiency and finance? The non-fast-track draft determinations are certainly more challenging on finance compared to Ofwat’s early view. Moreover,
The UK pharmaceutical industry, and in particular the generic medicines segment within it, has grown significantly in recent years. For example, the use of generic medicines has doubled between 2005 and 2017 to reach 75% of total prescriptions. At the same time, they account for only 28% of NHS spending on drugs valued at reimbursement prices.
In November 2018 Ofgem opened a consultation on changes to the way in which it recovers the costs of the networks used to transport electricity to homes, public organisations and businesses.In response to the consultation, energy companies Innogy, RES, ScottishPower and Vattenfall asked Oxera to review the analysis on which Ofgem had based its proposed Targeted Charging Review reforms.
The Federation of European Securities Exchanges (FESE) asked Oxera to examine how the EU’s Markets in Financial Instruments Directive (MiFID I), and more recently MiFID II, have affected equity markets, the role of price formation, and the impact of trading venues charging for market data.
European airports with more than 5m passengers per annum are regulated by the Airport Charges Directive (ACD), but the European Commission is considering whether to revise this. Oxera, in partnership with CMS, and on behalf of ACI Europe, developed a new practical way for member states to determine which airports face effective competition and could